EP 1596879 B1 20101222 - USE OF KAHALALIDE COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSORIASIS
Title (en)
USE OF KAHALALIDE COMPOUNDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSORIASIS
Title (de)
VERWENDUNG VON KAHALALIDE VERBINDUNGEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON PSORIASIS
Title (fr)
UTILISATION DE COMPOSES DE KAHALALIDE POUR LA FABRICATION D'UN MEDICAMENT POUR LE TRAITEMENT DE PSORIASIS
Publication
Application
Priority
- GB 2004000757 W 20040226
- GB 0304367 A 20030226
Abstract (en)
[origin: WO2004075910A1] Kahalalide compounds, in particular kahalalide F, are of use in a method to treat a mammal suffering from skin disease with avoiding toxicity and leading to clinical improvement.
IPC 8 full level
A61K 38/12 (2006.01); A61P 17/06 (2006.01); C07K 7/08 (2006.01); C07K 7/56 (2006.01); C07K 14/47 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP US)
A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 35/00 (2017.12 - EP); C07K 7/08 (2013.01 - EP US); C07K 7/56 (2013.01 - EP US); C07K 14/4748 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated extension state (EPC)
AL LT LV MK
DOCDB simple family (publication)
WO 2004075910 A1 20040910; AT E492285 T1 20110115; AU 2004216443 A1 20040910; AU 2004216443 B2 20090319; CA 2516458 A1 20040910; CA 2516458 C 20121127; CY 1111353 T1 20150805; DE 602004030661 D1 20110203; DK 1596879 T3 20110411; EP 1596879 A1 20051123; EP 1596879 B1 20101222; ES 2358018 T3 20110504; GB 0304367 D0 20030402; JP 2007527851 A 20071004; JP 4800194 B2 20111026; MX PA05009029 A 20051123; NZ 541493 A 20080731; PT 1596879 E 20110223; RU 2005115102 A 20060227; RU 2356908 C2 20090527; SI 1596879 T1 20110729; US 2007032412 A1 20070208; US 2008090757 A1 20080417; US 7323444 B2 20080129
DOCDB simple family (application)
GB 2004000757 W 20040226; AT 04714847 T 20040226; AU 2004216443 A 20040226; CA 2516458 A 20040226; CY 111100314 T 20110322; DE 602004030661 T 20040226; DK 04714847 T 20040226; EP 04714847 A 20040226; ES 04714847 T 20040226; GB 0304367 A 20030226; JP 2006502323 A 20040226; MX PA05009029 A 20040226; NZ 54149304 A 20040226; PT 04714847 T 20040226; RU 2005115102 A 20021018; SI 200431619 T 20040226; US 54675804 A 20040226; US 95014407 A 20071204